Toxins and virulence factors of enterotoxigenic Escherichia coli associated with strains isolated from indigenous children and international visitors to a rural community in Guatemala

Epidemiology and Infection

Volumn 143, Issue 8, 2015, Pages 1662-1671

  Torres, O R ^a   Gonzalez W ^a   Lemus, O ^b   Pratdesaba, R A ^a   Matute, J A ^c   Wiklund, G ^d   Sack, D A ^e   Bourgeois, A L ^e   Svennerholm, A M ^d  

^a Institute of Nutrition of Central America and Panama Guatemala   (Guatemala)

^b UNIVERSIDAD DE SAN CARLOS DE GUATEMALA   (Guatemala)

^c Centro de Investigaciones en Nutricion Y Salud   (Guatemala)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Diarrhoea; enteric bacteria; enterotoxin; Escherichia coli; travellers' infection

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; VIRULENCE FACTOR; BACTERIAL TOXIN; ENTEROTOXIN; ESCHERICHIA COLI PROTEIN; HEAT STABLE TOXIN (E COLI); HEAT-LABILE ENTEROTOXIN, E COLI;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDEMIC DISEASE; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GUATEMALA; HUMAN; INDIGENOUS PEOPLE; INFANT; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; RURAL POPULATION; TRAVELLER DIARRHEA; ADULT; DIARRHEA; ESCHERICHIA COLI INFECTIONS; GENETICS; METABOLISM; MICROBIOLOGY; POPULATION GROUP; PRESCHOOL CHILD; TRAVEL;

ADULT; BACTERIAL TOXINS; CHILD, PRESCHOOL; DIARRHEA; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GUATEMALA; HUMANS; INFANT; POPULATION GROUPS; RURAL POPULATION; TRAVEL; VIRULENCE FACTORS;

EID: 84929295149     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814002295     Document Type: Article

References (41)

1. World Bank. World Bank data on Guatemala (http://data.worldbank.org/country/guatemala). Accessed 12 June 2013.
2. United Nations Development Programme. Explanatory note on 2013 HDR composite indices: Guatemala. In: Malik K, et al. Human Development Report 2013 - The Rise of the South: Human Progress in a Diverse World. New York: United Nations Development Programme, 2013. (http://hdr.undp.org/sites/default/files/Country-Profiles/GTM.pdf). Accessed 20 December 2013.
3. WHO. World Health Organization data on diarrhoeal diseases (http://www.who.int/vaccine-research/diseases/diarrhoeal/en/index4.html). Accessed 13 June 2013.
4. Qadri F, et al. Enterotoxigenic E. coli in developing countries: epidemiology, microbiology, clinical features, treatment and prevention. Clinical Microbiology 2005; 18: 465-483.
5. Wennerås C, Ehrling V. Prevalence of enterotoxigenic Escherichia coli associated diarrhea and carrier state in the developing world. Journal of Health, Population and Nutrition 2004; 22: 370-382.
6. Qadri F, et al. Prevalence of toxin types and colonization factors in ETEC isolated during a 2-year period from diarrheal patients in Bangladesh. Journal of Clinical Microbiology 2000; 38: 27-31.
7. Cruz JR, et al. Epidemiology of persistent diarrhea among Guatemalan rural children. Acta Pediatrica Supplement 1992; 381: 22-26.
8. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clinical Microbiology Reviews 1998; 18: 142-201.
9. Gaastra W, Svennerholm A-M. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends in Microbiology 1996; 4: 444-452.
10. Walker RI, Steele D, Aguado T. Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease. Vaccine 2007; 25: 2545-2566.
11. Committing to Child Survival. A Promise Renewed. Dashboard on under-five mortality data (http://www.apromiserenewed.org/Dashboard.html). Accessed 13 June 2013.
12. Ellingsworth L. Transcutaneous immunization and the travelers' diarrhea vaccine system: a phase III pivotal efficacy study [Abstract]. 6th International Conference on Vaccines for Enteric Diseases 2011, Cannes, France.
13. Frech SA, et al. Protection against travelers' diarrhea in a randomized, double-blind, placebo-controlled filed trial of a patch containing heat-labile toxin from Escherichia coli. Lancet 2008; 371: 2019-2025.
14. Nicklasson M, et al. Enterotoxigenic Escherichia coli multilocus sequence types in Guatemala and Mexico. Emerging Infectious Diseases 2010; 16: 143-146.
15. Begum YA, et al. Shift in phenotypic characteristics of enterotoxigenic Escherichia coli (ETEC) isolated from diarrheal patients in Bangladesh. PLoS Neglected Tropical Diseases 2014; 8: e3031.
16. Mansour A, et al. Pathogenicity and phenotypic characterization of enterotoxigenic Escherchia coli isolates from a birth cohort of children in rural Egypt. Journal of Clinical Microbiology 2014; 52: 587-591.
17. Isidean SD, et al. A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine 2011; 29: 6167-6178.
18. Sack DA, et al. Randomized double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhea of travelers to Guatemala and Mexico. Vaccine 2007; 25: 4392-4400.
19. Bourgeois AL, et al. Protective efficacy of an oral killed vaccine (OKV) for enterotoxigenic E. coli (ETEC) in adult travelers to Guatemala (GU) and Mexico (MX) [Abstract]. 45th Annual ICAAC Meeting 2005, Washington, DC, USA.
20. Taylor DN, et al. A randomized, double-blind, multicenter study of Rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. American Journal of Tropical Medicine and Hygiene 2006; 74: 1060-1066.
21. Svennerholm A-M, et al. Monoclonal antibodies against Escherichia coli heat-stabile toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 1986; 24: 585-590.
22. Sjöling Å, et al. Comparative analyses of phenotypic and genotypic methods for detection of enterotoxigenic Escherichia coli toxins and colonization factors. Journal of Clinical Microbiology 2007; 45: 3295-3301.
23. Nicklasson M, et al. Mutations in the periplasmic chaperone leading to loss of surface expression of the colonization factor CS6 in enterotoxigenic Escherichia coli (ETEC) clinical isolates. Microbial Pathogenesis 2008; 44: 246-254.
24. Rodas C, et al. Development of multiplex PCR assays for detection of enterotoxigenic Escherichia coli colonization factors and toxins. Journal of Clinical Microbiology 2009; 47: 1218-1220.
25. Binsztein N, et al. Colonization factors of enterotoxigenic Escherichia coli isolated from children with diarrhea in Argentina. Journal of Clinical Microbiology 1991; 29: 1893-1898.
26. Paniagua M, et al. Analysis of incidence of infection with enterotoxigenic Escherichia coli in a prospective cohort study of infant diarrhea in Nicaragua. Journal of Clinical Microbiology 1997; 35: 1404-1410.
27. Riviera FP, et al. Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children. Journal of Clinical Microbiology 2010; 48: 3198-3203.
28. Rodas C, et al. Enterotoxins, colonization factors, serotypes and antimicrobial resistance of enterotoxigenic Escherichia coli (ETEC) strains isolated from hospitalized children with diarrhea in Bolivia. Brazilian Journal of Infectious Diseases 2011; 15: 132-137.
29. p gentoypes is associated with diarrhea both in children and in areas of endemicity and in travelers. Journal of Clinical Microbiology 2006; 44: 3872-3877.
30. Nicklasson M, et al. Genetic relationship of enterotoxigenic Escherichia coli strains expressing heat-stable enterotoxin and coli surface antigen 6 in Guatemala and Mexico. Emerging Infectious Diseases 2010; 16: 143-146.
31. Steinsland HP, et al. Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau. Journal of Infectious Diseases 2002; 186: 1740-1747.
32. Kotloff KL, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382: 209-222.
33. Clemens J, et al. Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method. Journal of Infectious Diseases 2004; 189: 2299-2307.
34. Harris AM, et al. Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. American Journal of Tropical Medicine and Hygiene 2008; 79: 708-714.
35. McKenzie R, et al. Volunteer challenge with enterotoxigenic Escherichia coli that express intestinal colonization factor fimbriae CS17 and CS19. Journal of Infectious Diseases 2011; 204: 60-64.
36. Jiang ZD, et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). Journal of Infectious Diseases 2002; 185: 497-502.
37. Nirdnoy W, et al. Distribution of colonization factor antigens among enterotoxigenic Escherichia coli strains isolated from patients with diarrhea in Nepal, Indonesia, Peru, and Thailand. Journal of Clinical Microbiology 1997; 35: 527-530.
38. Rao M, et al. High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children. Journal of Clinical Microbiology 2003; 41: 4862-4864.
39. Peruski LF, et al. Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt. Journal of Clinical Microbiology 1999; 37: 2974-2978.
40. Qadri F, et al. Disease burden due to enterotoxigenic Escherichia coli in the first two years of life in an urban community in Bangladesh. Infection and Immunity 2007; 75: 3961-3968.
41. Svennerholm A-M, Lundgren A. Recent progress toward an enterotoxigenic Escherichia coli vaccine. Expert Reviews of Vaccines 2012; 11: 495-507.